The global lateral-flow-assay market was valued at USD 10.0 billion in 2024 and is projected to witness steady growth over the forecast period. Supported by increasing demand for rapid diagnostics across healthcare, pharmaceuticals, and point-of-care testing, the market is expected to reach USD 18.0 billion by 2035. This growth trajectory represents a compound annual...